Related references
Note: Only part of the references are listed.Acute lymphoblastic leukemia in the elderly
A. Delannoy et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission
David I. Marks et al.
BLOOD (2008)
Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia
Lei Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)
Anthony H. Goldstone et al.
BLOOD (2008)
Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)
Heike Pfeifer et al.
BLOOD (2007)
Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: Results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial
Claude Gardin et al.
BLOOD (2007)
Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL)
Oliver G. Ottmann et al.
CANCER (2007)
Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy:: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol
Marco Vignetti et al.
BLOOD (2007)
Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia:: a trial by the Acute Leukemia French Association (ALFA) Group
X. Thomas et al.
LEUKEMIA (2007)
Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia:: results of the GRAAPH-2003 study
Adrienne de Labarthe et al.
BLOOD (2007)
Cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients age 60 years or older with previously untreated acute myeloid leukemia
Francis Giles et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase 1/2 study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemia
Guillermo Garcia-Manero et al.
BLOOD (2006)
Adolescents with acute lymphoblastic leukaemia: Emerging from the shadow of paediatric and adult treatment Protocols
Ramya Ramanujachar et al.
PEDIATRIC BLOOD & CANCER (2006)
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)
Barbara Wassmann et al.
BLOOD (2006)
Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study
A. Delannoy et al.
LEUKEMIA (2006)
Clofarabine and cytarabine combination as induction therapy for acute myeloid leukemia (AML) in patients 50 years of age or older
S Faderl et al.
BLOOD (2006)
Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia - A metaanalysis
Masamitsu Yanada et al.
CANCER (2006)
Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia
T Büchner et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia
DA Thomas et al.
CANCER (2006)
Treatment of older patients with acute myeloid leukemia - New agents
AK Burnett et al.
SEMINARS IN HEMATOLOGY (2006)
High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia:: A phase II study by the Japan Adult Leukemia Study Group
M Yanada et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993
JM Rowe et al.
BLOOD (2005)
Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
KH Lee et al.
LEUKEMIA (2005)
Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia
MA Sanz et al.
BLOOD (2005)
Acute lymphoblastic leukemia in elderly: The Polish Adult Leukemia Group (PALG) experience
T Robak et al.
ANNALS OF HEMATOLOGY (2004)
Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy:: a multicenter study by the PETHEMA group
MA Sanz et al.
BLOOD (2004)
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia
H Kantarjian et al.
CANCER (2004)
Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands
JM de Bont et al.
LEUKEMIA (2004)
Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT:: a GOELAMS trial
M Hunault et al.
BLOOD (2004)
Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate
DA Thomas et al.
BLOOD (2004)
Outcome of treatment in adults with acute lymphoblastic leukemia:: Analysis of the LALA-94 trial
X Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia
B Löwenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
BC Bostrom et al.
BLOOD (2003)
Use of arsenic trioxide (AS2O3) in the treatment of patients with acute promyelocytic leukemia -: The M. D.!Anderson experience
G Lazo et al.
CANCER (2003)
Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults?: Comparison of the French FRALLE-93 and LALA-94 trials
N Boissel et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia
H Hallböök et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study
J Takeuchi et al.
LEUKEMIA (2002)
Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia
C Linker et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study
L Annino et al.
BLOOD (2002)
Treatment of acute lymphoblastic leukemia in the elderly: An evaluation of interferon alpha given as a single agent after complete remission
A Delannoy et al.
LEUKEMIA & LYMPHOMA (2002)
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: Results of cancer and leukemia group B study 9251
EJ Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Intensive timed sequential remission induction chemotherapy with high-dose cytarabine for childhood acute myeloid leukemia
DM Loeb et al.
MEDICAL AND PEDIATRIC ONCOLOGY (2001)
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia
SL Soignet et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Acute lymphoblastic leukemia in the elderly:: The Edouard Herriot Hospital experience
X Thomas et al.
AMERICAN JOURNAL OF HEMATOLOGY (2001)
Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation -: A follow-up report of the French protocol LALA 87
A Thiebaut et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2000)
Results of treatment with Hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia
HM Kantarjian et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
